Page last updated: 2024-08-26

norverapamil and rifampin

norverapamil has been researched along with rifampin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chibale, K; Kumar, M; Naran, K; Pavadai, E; Ruminski, PG; Singh, K; Warner, DF1
Lennernäs, H; Sandström, R1
Barter, Z; Jamei, M; Neuhoff, S; Rostami-Hodjegan, A; Turner, DB; Yeo, KR1
Abate, G; Campbell, M; Chibale, K; Eickhoff, CS; Hamzabegovic, F; Hoft, DF; Kumar, M; Ruminiski, PG; Selimovic, A; Singh, K1

Other Studies

4 other study(ies) available for norverapamil and rifampin

ArticleYear
Synthesis of new verapamil analogues and their evaluation in combination with rifampicin against Mycobacterium tuberculosis and molecular docking studies in the binding site of efflux protein Rv1258c.
    Bioorganic & medicinal chemistry letters, 2014, Jul-15, Volume: 24, Issue:14

    Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Binding Sites; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Rifampin; Structure-Activity Relationship; Verapamil

2014
Repeated oral rifampicin decreases the jejunal permeability of R/S-verapamil in rats.
    Drug metabolism and disposition: the biological fate of chemicals, 1999, Volume: 27, Issue:8

    Topics: Algorithms; Animals; Antibiotics, Antitubercular; Calcium Channel Blockers; Glucose; Intestinal Absorption; Jejunum; Male; Perfusion; Rats; Rats, Sprague-Dawley; Rifampin; Stereoisomerism; Verapamil

1999
Application of permeability-limited physiologically-based pharmacokinetic models: part II - prediction of P-glycoprotein mediated drug-drug interactions with digoxin.
    Journal of pharmaceutical sciences, 2013, Volume: 102, Issue:9

    Topics: Adjuvants, Anesthesia; Anti-Arrhythmia Agents; ATP Binding Cassette Transporter, Subfamily B; Computer Simulation; Digoxin; Drug Interactions; Enzyme Inhibitors; Humans; Midazolam; Models, Biological; Permeability; Rifampin; Verapamil

2013
New Verapamil Analogs Inhibit Intracellular Mycobacteria without Affecting the Functions of Mycobacterium-Specific T Cells.
    Antimicrobial agents and chemotherapy, 2015, Dec-07, Volume: 60, Issue:3

    Topics: Animals; Autophagy; Humans; Isoniazid; Leukocytes, Mononuclear; Macrophage Activation; Macrophages; Mice, Transgenic; Mycobacterium bovis; Mycobacterium tuberculosis; Rifampin; T-Lymphocytes; Verapamil

2015